SYNLAB AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.13 EUR | +0.27% |
|
+0.18% | -2.45% |
| 10/06 | After cyber attack: British hospitals urgently need blood donations | DP |
| 04/06 | Hackers attack laboratory chain Synlab again: 'repercussions' for patients | DP |
| Sales 2024 * | 286.2Cr 308.66Cr 26TCr | Sales 2025 * | 302.4Cr 326.13Cr 27TCr | Capitalization | 243.95Cr 263.09Cr 22TCr |
|---|---|---|---|---|---|
| Net income 2024 * | 8.1Cr 8.74Cr 729.6Cr | Net income 2025 * | 6.7Cr 7.23Cr 603.5Cr | EV / Sales 2024 * | 1.37 x |
| Net Debt 2024 * | 147.05Cr 158.59Cr 13TCr | Net Debt 2025 * | 163.85Cr 176.71Cr 15TCr | EV / Sales 2025 * | 1.35 x |
| P/E ratio 2024 * |
30
x | P/E ratio 2025 * |
37
x | Employees | 27,000 |
| Yield 2024 * |
1.85% | Yield 2025 * |
1.85% | Free-Float | 14.25% |
More Fundamentals
* Assessed data
More news
Latest transcript on SYNLAB AG
More press releases
More news
| 1 day | +0.27% | ||
| 1 week | +0.18% | ||
| Current month | +0.54% | ||
| 1 month | +8.37% | ||
| 3 months | +0.27% | ||
| 6 months | -3.21% | ||
| Current year | -2.45% |
1 week
10.98
11.18
1 month
10.2011.24
Current year
10.1012.43
1 year
8.0212.43
3 years
6.6825.00
5 years
6.6825.00
10 years
6.6825.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 56 | 26/21/26 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 26/21/26 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 11/21/11 |
| Founder | 63 | 01/98/01 | |
Peter Catterall
BRD | Director/Board Member | 56 | 11/21/11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.29% | 125 M€ | -.--% | - | |
| 0.55% | 17 M€ | -.--% | - | |
| 0.18% | 18 M€ | +7.68% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 11.14 | +0.36% | 1 906 |
| 12/24/12 | 11.1 | 0.00% | 21,174 |
| 11/24/11 | 11.1 | 0.00% | 16,671 |
| 10/24/10 | 11.1 | 0.00% | 70,497 |
| 07/24/07 | 11.1 | -0.18% | 6,908 |
Delayed Quote Xetra, June 13, 2024 at 04:03 pm IST
More quotes
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Calendar
08/08/2024
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.1
EUR
Average target price
14.5
EUR
Spread / Average Target
+30.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.45% | 264.62Cr | |
| -21.29% | 804.7Cr | |
| +77.60% | 456.21Cr | |
| +7.76% | 274.4Cr | |
| -49.62% | 202.36Cr | |
| -13.10% | 179.56Cr | |
| -20.79% | 146.16Cr | |
| +16.24% | 119.75Cr | |
| -44.65% | 112.77Cr | |
| +19.41% | 101.05Cr |
- Stock Market
- Equities
- SYAB Stock
